|
ZNF516 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.857400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.161200E-03 |
| Normal-vs-Stage2 |
9.005800E-01 |
| Normal-vs-Stage3 |
1.321870E-03 |
| Normal-vs-Stage4 |
5.639000E-03 |
| Stage1-vs-Stage2 |
8.938100E-02 |
| Stage1-vs-Stage3 |
5.27590005017231E-09 |
| Stage1-vs-Stage4 |
1.5282599999944E-05 |
| Stage2-vs-Stage3 |
6.223600E-02 |
| Stage2-vs-Stage4 |
5.592400E-02 |
| Stage3-vs-Stage4 |
7.732600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.668600E-01 |
| Normal-vs-AfricanAmerican |
9.815800E-01 |
| Normal-vs-Asian |
5.226600E-01 |
| Caucasian-vs-AfricanAmerican |
9.066400E-01 |
| Caucasian-vs-Asian |
5.070600E-01 |
| AfricanAmerican-vs-Asian |
5.314400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.280200E-01 |
| Normal-vs-Female |
9.197000E-01 |
| Male-vs-Female |
8.474200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.782200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.956400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.015830E-01 |
| Normal-vs-Age(81-100Yrs) |
2.838200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.707400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.472000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.996800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.104410E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.106440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.092400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.736300E-03 |
| Normal-vs-Grade 2 |
1.302120E-02 |
| Normal-vs-Grade 3 |
9.173800E-02 |
| Normal-vs-Grade 4 |
1.53778999999465E-05 |
| Grade 1-vs-Grade 2 |
4.958100E-02 |
| Grade 1-vs-Grade 3 |
1.405410E-04 |
| Grade 1-vs-Grade 4 |
3.551700E-04 |
| Grade 2-vs-Grade 3 |
4.27870000000441E-05 |
| Grade 2-vs-Grade 4 |
9.97120164214493E-11 |
| Grade 3-vs-Grade 4 |
2.435700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.870000E-02 |
| Normal-vs-ccB subtype |
4.836800E-01 |
| ccA subtype-vs-ccB subtype |
9.717000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.261200E-01 |
| Normal-vs-N1 |
1.294020E-01 |
| N0-vs-N1 |
2.041400E-01 |
|
|
